Loading…
Nimbus Therapeutics is a biotechnology company that designs and develops highly selective small molecule medicines for oncology, immunology, and metabolic indications. The company combines world-class expertise in computational drug design and translational medicine to create targeted therapies with exquisite selectivity.
AI named Nimbus Therapeutics in February 2026.